FDA approves Insys Subsys fentanyl sublingual spray
The US Food and Drug Administration (FDA) has approved Insys Therapeutics' Subsys fentanyl single-dose sublingual spray.
Subsys fentanyl sublingually formulation is administered in a delivery device which provides benefits to patients experiencing episodes of cancer pain.
Insys president and CEO Michael Babich said they intend to continue to grow their commercial organization and introduce this product under the recently approved TIRF REMS Access Program when it is launched later this quarter.
Related Insight
Suppliers Directory
Inzign - Plastics Injection Moulding and Assembly Disposable Medical Devices
Inzign is a B2B contract manufacturer specialising in plastics injection moulding and assembly disposable medical devices and has since advanced from a vendor to that of a reliable business partner for its clients. Inzign has since grown from strength to strength with a population of 160 employees and with footprints in Singapore and Indonesia.
Specialty Devices > Drug Delivery Devices > Suppliers
Specialty Devices
Anesthesia & Respiratory Devices
Cardiovascular Devices
Dental Devices
Diabetes Care Devices
Drug Delivery Devices
Orthopedic Devices
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Drug Delivery Devices Intelligence
Medisize Brochure
Published by Phillips-Medisize
Specialty Devices > Drug Delivery Devices > White Papers
Merger Between Phillips and Medisize
Published by Phillips-Medisize
Specialty Devices > Drug Delivery Devices > White Papers
Buy the latest industry research online today!
External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500
Comments may be moderated for spam, obscenities or defamation.